CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Esketamine, the ketamine-derived nasal spray sold under the brand name Spravato (esketamine), is indicated for patients with treatment-resistant depression. In October 2023, the FDA warned about ...

This article looks at the rationale behind the combined use of acetylcholinesterase inhibitors and the N-methyl-D-aspartate-receptor antagonist, memantine, from both preclinical and clinical ...

Elon Musk said in a March 2024 interview that he takes ketamine to treat depression. He claimed to have a doctor's prescription for the drug. How often, or under what circumstances, he uses ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours remission, and ketamine is also being marketed for post-traumatic stress ...

A man who admits being addicted to the so-called party drug Ketamine says it has had a devastating impact on his life, leaving him needing bladder surgery. George is among a number of young people ...